image
Healthcare - Biotechnology - NASDAQ - US
$ 2.02
-2.88 %
$ 230 M
Market Cap
-1.23
P/E
INCOME STATEMENT
63.5 M REVENUE
-34.03%
-191 M OPERATING INCOME
38.22%
-161 M NET INCOME
42.88%
EFFICIENCY
Earnings Waterfall Fate Therapeutics, Inc.
image
Revenue 63.5 M
Cost Of Revenue 162 M
Gross Profit -98.2 M
Operating Expenses 254 M
Operating Income -191 M
Other Expenses -29.6 M
Net Income -161 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
REVENUE
Revenue 63.5 96.3 55.8 31.4 10.7 4.7 4.1 4.4 2.4 0 1.0 2.7 1.2
GROSS PROFIT
Cost Of Revenue 161.7 13.8 5.8 125.6 87.8 56.0 34.4 26.5 19.9 16.4 12.0 12.0 0
Gross Profit (98.2) 82.5 50.0 (94.2) (77.1) (51.3) (30.3) (22.1) (17.4) (16.4) (11.0) (9.3) 1.2
OPERATING INCOME
Operating Expenses 254.0 404.7 272.8 159.5 111.4 71.8 46.2 36.4 30.2 24.9 18.6 16.2 14.5
Selling, General and Administrative Expenses 79.4 84.2 57.3 33.9 23.6 15.8 11.9 9.9 10.4 8.5 6.6 4.2 4.6
Research and Development Expenses 172.6 320.5 215.5 125.6 87.8 56.0 34.4 26.5 19.9 16.4 12.0 12.0 9.9
Operating Income (190.5) (308.4) (217.0) (128.1) (100.7) (67.1) (42.1) (32.0) (27.8) (24.9) (17.7) (13.6) (13.3)
PRE-TAX INCOME
Interest Income Expense 0 5.8 0 0 1.8 1.7 1.3 1.6 2.2 0.5 0.8 0.5 0.1
Total Other Income 29.6 26.7 4.8 (45.3) 2.6 0.5 (0.8) (1.5) (2.2) (1.0) (3.2) (0.7) (0.1)
Pre-Tax Income (160.9) (281.7) (212.2) (173.4) (98.1) (66.6) (43.0) (33.5) (30.0) (25.9) (20.9) (14.2) (13.4)
NET INCOME
Tax Provision 0 (26.7) (5.8) (3.1) (0.4) 2.2 0.3 (0.7) (0.7) 53 K 0.8 0.5 0.1
Net Income (160.9) (255.1) (206.3) (170.3) (97.7) (66.6) (43.0) (33.5) (30.0) (25.9) (20.9) (14.2) (13.4)
EPS 1.64 2.63 2.18 2.07 1.43 1.19 1.02 1.05 1.18 1.27 3.54 1.61 1.51